| Model Number |
M635WU50310 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/27/2025
|
|
Type of Reportable Event
|
Death
|
|
Event or Problem Description
|
|
Reported via clinical study.It was reported that patient death occurred.A left atrial appendage (laa) closure procedure was performed.A 31mm watchman flx laa closure device was implanted on (b)(6) 2023, with complete laa seal and deployed device diameter of 26.0 mm.The patient was discharged the same day on a medication regime of aspirin (81 mg/day) and rivaroxaban (20 mg/day).On (b)(6) 2025, 829 days post index procedure, the patient was reported to have passed away.No additional information on the cause of death was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
With all the available information, boston scientific (bsc) concludes: device technical analysis: the watchman flx? remains implanted; therefore, returned device analysis could not be completed.Device history record review: a review was completed of the device history records (dhr) for the watchman flx?, part # m635wu50310 batch # 0030420153.The device was processed through all normal operational conditions and passed all acceptance activities.The dhr review did not identify any deviations or non-conformances that could have contributed to the event.Labeling review: there was no evidence to suggest that the device was used in a manner inconsistent with the labeling.Watchman flx? instructions for use (ifu) lists potential complications, risks and adverse events that may be associated with the use of this device which include death.Risk review: a risk review was completed and confirmed that the event of death was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
|
| |
|
Event or Problem Description
|
|
Reported via clinical study.It was reported that patient death occurred.A left atrial appendage (laa) closure procedure was performed.A 31mm watchman flx laa closure device was implanted on (b)(6) 2023, with complete laa seal and deployed device diameter of 26.0 mm.The patient was discharged the same day on a medication regime of aspirin (81 mg/day) and rivaroxaban (20 mg/day).On (b)(6) 2025 ,829 days post index procedure, the patient was reported to have passed away.No additional information on the cause of death was provided.
|
| |
|
Search Alerts/Recalls
|